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Background: The prevalence of diabetes has been growing rapidly in developing countries. This causes devastating
economic burdens and increases demands on the health care system. Therefore, there is an urgent need to find a
cost-effective and multi-faceted approach for diabetes care. Peer support models provide a potentially low-cost, flexible
means which complements the current existing health care services. In this way, trained peer leaders can become
qualified extensions to a formal healthcare system, capable of assisting education delivery and bolstering the efforts of
professional staff. As such, creating a cultural specific peer support program and determining whether it is acceptable
and cost-effective in rural communities of China is crucial. This study aims to implement and evaluate biophysical and
psychosocial outcomes of peer support program for people with type 2 diabetes in rural communities, and to explore
the program’s feasibility and sustainability in China.
Methods/Design: This study is a cluster randomised controlled trial. All consenting patients will be randomised by
community staff members to receive either peer support or the control care. The data collection and analysis including
social demographics, health status, psychosocial status, economic status and biomedical measures will be collected at
baseline, 6 months, and 12 months. The primary indicator measured is the change in HbA1c, whereas secondary
indicators include biophysical, psychosocial functioning and other lifestyle factors. Finally, economic evaluations will
determine whether the program is cost effective.
Discussion: This protocol is a cluster randomized, controlled trial of group-based peer support for people with type 2
diabetes in the community settings of rural China. Results from this trial may provide evidence to the effectiveness of
peer support; furthermore, they will provide valuable information concerning the acceptability and feasibility of a new
approach to improve diabetes self-management among resource-constrained settings.
Trial registration: ClinicalTrials.gov Identifier: NCT02119572, April 18, 2014.
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Diabetes is a growing health problem worldwide. It is
estimated that 382 million people live with diabetes
around the world, and by 2035, that number will surge
to 592 million [1]. Diabetes mellitus imposes a huge
economic burden on national health care systems globally.* Correspondence: sunzilin1963@126.com
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forecasted to increase 30% to 34% from 2010. Developing
countries will experience a twenty-year growth rate of
67% while the developed countries will have a rate of
27% [2]. A systematic review showed that diabetes
affects 6.8%, or one out of every 15 people living in
rural areas worldwide. From 1990–2010, the prevalence
in low-middle income countries grew fourfold, while in
high-income countries, the prevalence was twofold higher
[3]. Furthermore, rural populations often live in worse
socioeconomic conditions and have poor literacy skills. This is an Open Access article distributed under the terms of the Creative
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iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Xie et al. BMC Public Health 2014, 14:747 Page 2 of 7
http://www.biomedcentral.com/1471-2458/14/747compared with their urban counterparts [4]. As such,
there is an urgent need to find innovative and effective
solutions to help citizens in rural communities especially
in low-middle income countries to successfully manage
diabetes [5].
China has the largest number of individuals with
diabetes mellitus; 113.9 million (11.6%) adults at age
18 or older have diabetes and 493.4 million adults
(50.1%) are pre-diabetic. The prevalence of diabetes and
pre-diabetes in rural areas is an estimated 10.3% and
50.9% respectively [6]. Considering the problem of a
growing diabetic population, health professional shortages,
and an under-financed health care system in China, a
effective strategy is crucial. Providing education programs
to a fast growing number of people with diabetes, par-
ticularly the poor and less-educated rural community,
presents a huge challenge to Chinese health care system. To
improve diabetes care and positively influence health out-
comes, new approaches need to be developed that are both
effective and feasible in Chinese rural communities [7].
Nowadays, peer support models have been widely recog-
nized as a promising solution. The concept of peer support
emphasizes a patient-centered approach as “the provision
of emotional, appraisal and informational assistance by a
created social network member who possesses experiential
knowledge of a specific behavior or stressor and similar
characteristics as the target population, to address a health-
related issue of a potentially or actually stressed focal
person” [8]. Although the WHO reviewed the use of peer
support programs for people with diabetes and found
numerous patient benefits, such as glycemic control and
increase in quality of life, further evaluations are needed
before peer support interventions can be integrated into
the existing policy for diabetes management [9]. A system-
atic review by Jeremy Dale and colleagues found that
peer support programs exhibit a latent potential towards
improving health outcomes in adults living with diabetes.
However the evidence-based review also identified the
evaluation’s inconsistency and limitations, emphasizing
the need for additional data related to cost effectiveness
in future research [10]. This study will seek to show
that peer support models provide a potentially low-cost,
flexible compliment to formal health care services [11].
Trained peer leaders can become extensions, or adjuncts
to a formal healthcare system, thereby assisting with
education delivery and bolstering the efforts of health
care professionals [7]. In the current Chinese health care
system, diabetes education has not been incorporated, and
rural populations with diabetes have not yet acknowledged
the responsibility for their own disease or adopted recom-
mended health behaviors. A survey using anonymous
standardized patients showed that baseline-educated
rural clinicians are not yet prepared to act as the front
line fighters in China’s primary care system, or equippedto tackle problems in health education [12].Therefore,
exploring effective strategies to support diabetes in rural
communities is desperately needed.
This article is a study protocol for a cluster randomised
controlled trial for a peer support programs in a rural
community within China. Our aim is to implement and
evaluate a peer support program for people with type 2
diabetes within a specified local rural community. This
program is designed to allow the participants to meet and
share their self-management challenges, to explore and
develop strategies to overcome these challenges, as well as
sustain health behavior change using the experience
and support derived from the groups. This study will give
valuable information about the effectiveness, acceptability
and feasibility of a novel way to improve diabetes self-
management among developing countries.
Methods
Objectives
This study aims to implement and evaluate the biophysical
and psychosocial outcomes of a culturally specific peer
support program using a cluster randomized controlled
trial in patients with type 2 diabetes and to determine
whether it is an acceptable, cost effective intervention
in the rural community health care centers. The study’s
objectives are as follows:
1. To establish a culturally appropriate and feasible
diabetes peer leader education curriculum by
assessing participants’ adaptiveness to curriculum
components, changes in trainees’ knowledge,
attitudes, self-care skills and peer support outcomes.
2. To establish a diabetes management network
between the hospital, the community, and peer
groups, and explore its feasibility and sustainability.
3. To assess the following measures across peer
support and control groups: HbA1c, AGE, blood
lipids, blood glucose, blood pressure, BMI,
medication adherence, knowledge, reported
self-efficacy, self-care activities, quality of life, trait
affect, life satisfaction, depression, anxiety, and stress.
4. To evaluate differences in cost efficiency between
the intervention group and the comparison group.
Study design and setting
This study is a cluster randomised controlled trial imple-
mented and reported in accordance with the requirements
of the CONSORT statement [13] and its extension to
cluster randomised trials [14]. The participants were ran-
domly designated to either an intervention arm, which
implements the usual care system and the peer support
intervention, or a control arm which implements a
usual care system, with geographical location being the
unit of cluster randomisation.
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receive primary health care at 12 rural community health
centres located in Liu-he District, Nanjing, and Gao-
gou Town, Huaian, in Jiang Su province. The study
team coordinates and works hand-in-hand with the staff
members at each community health centres to implement
and monitor the study.
Figure 1 is a CONSORT diagram of the study design.
Ethics
Approval to conduct this study has been granted by the
Committee on Human Research (Institutional Review
Board) at Zhong Da Hospital, Southeast University (2012
ZDLLKY05.0). Written informed consent was obtained
from all trial participants after providing sufficient time to
consider partaking in the study, read the details provided
on the Patient Information Sheet, in addition to ask and




1) Patients with type 2 diabetes and HbA1c ≤ 7.5%;
2) Insulin injection experience is preferred,
3) Can commit to attending a 20-hour training,
organize activities with other patients every month
and attend a leadership meeting at least twice a year,
4) Have basic diabetes self-management knowledge and
supportive, non-judgmental communication skills,
5) Willing to lead.Peer leade
half a year
Peer leader 
6 and 12 Month Measurements





Regular assistance for peers
Education class every 2 month 
6 and 12 Mont
Figure 1 Peer support for patients with type 2 diabetes in Nanjing––Exclusion criteria:
1) Patients with unstable mood or major psychiatric
conditions,
2) Physical disability or severe speech impediment
which may influence communication with others,
3) Patients with other serious health conditions (e.g.,





1) Patients with type 2 diabetes,
2) Declaration of voluntary participation in the study
with signed informed consent form,
3) Reside in local community during the intervention
period.
Exclusion criteria:
1) Patients with unstable mood or major psychiatric
conditions,
2) Patients with serious diabetes complications (e.g.,
blindness) that would impede meaningful
participation in the program,
3) Patients with other serious health conditions (e.g.,
terminal cancer) or life expectancy less than
12 months,
4) Patients currently enrolled in other research program.r meeting
training 
rural communities
Randomisation of locations, stratified 
by health region with block size 
CONTROL ARM
Control
Education class every 2 
month
h Measurements
Consort diagram for diabetes project study design.
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Participants
Whether on self-recommendation or recommendation
by clinicians and staff members, all peer leader candi-
dates will follow a strict selection procedure from which
eligible peer leaders are identified. Additional patients
were also selected from primary health care settings
and recruited from posted flyers. Primary care clinicians
reviewed search results and excluded patients. The study
team contacted eligible patients via phone calls to explain
the study and arranged enrolment appointments.
Group allocation
Community health centres will be stratified by size and
existing structure of primary diabetes care service. Allo-
cation to intervention or control group is governed by




Peer leaders are required to attend twenty-hour structured
training programs in their community which were led
by the study team. The training was conducted using a
standardised training curriculum developed by the
research team. The training team comprised of endo-
crinology physicians, certified diabetes educators (nurses),
registered dieticians, exercise physiologists, psychiatrists,
traditional Chinese medicine specialists, and communica-
tion trainers. The program aimed at enhancing diabetes
knowledge and promoting diabetes self-care behavior.
The Peer Leader Training (PLT) curriculum utilizes mul-
tiple educational approaches (such as lecture, practise,
seminar and etc.) and consists of 5 major components.
The content covers basic knowledge of diabetes, behavior
change skills, and communication techniques, organi-
sational management methods highlighting individual
responsibilities and group management techniques, as
well as psychological support.
Control group
The sessions for the control groups were interactive
and informal. Participants were given a handbook that
introduces issues in the training session. Patients attend
the self-management training and communicate with
the professionals every two months to obtain information
on diabetes diet, exercise, glucose monitoring, etc. Add-
itionally, group members will attend three follow ups at
baseline, 6 months, and 12 months.
Intervention group
Patients are divided into groups of 8–15 people and
assigned to peer leaders for 12 months according to
their area of residence. In addition to receiving the sametraining and follow-ups as the control group, patients
from intervention groups were suggested and encouraged
to take part in monthly group activities with peer leaders.
If possible, casual activities (such as phone calls, WeChat
voice messages, physical exercises, group member’s family
visits, shopping together, etc.) are also recommended. The
first meeting is an introductory discussion of group mem-
bers’s backgrounds and their disease history, through
which the leaders established understanding and relation-
ship with the peers. In subsequent interactions, the leader
and peers will discuss the following issues: their current
and target values for HbA1c, blood lipids and blood pres-
sure; self management skills such as using a glucose meter
and appropriate strategies for hypoglycaemia; lifestyle
changes around healthy diets, physical activities, foot care,
and stress control. The subsequent monthly activities
include interactions designed by the research team, peer
leaders, as well as college student volunteers. Several
cultural group activities will be organized such as Chinese
hand calisthenics and body calisthenics, how to choose
daily nutritional meals, knowledge competition, and sing-
ing songs that were integrated with health education
topics. Group members also shared similar experiences
on lifestyle, family life, personal hobbies and experiences
to support each other in achieving goals. Peer leaders
documented each encounter and recorded each time
the date, number of participants, the nature of encounter,
approximate duration of contact, and topics discussed.
In addition, peer leader meeting will be held every six
months. In the leader meetings, peer leaders will share
their experiences and discussed the problems they con-
fronted in their groups. The research team will aid them
discover the solutions and provide them with further
training when necessary.
Sample size calculation
Sample size and power calculations are performed for
the main outcome of interest-difference in mean HbA1c
levels-using effect sizes and standard deviations derived
from multiple published trials of patient-education inter-
ventions. Using a non-inferiority design based on clinically
relevant difference of HbA1c of 0.5%, standard deviation
of 1.5, and groups of 8–15 participants per randomisation
group for 80% power at two-sided 5% significance, 150
participants are required to complete the study proce-
dures. Allowing for a 20% drop-out from randomisation
to completion of the trial, it is anticipated that we would
require 180 subjects in each arm to be randomised in
the study.
Data collection and outcome measures
Data will be collected at baseline, 6 months and 12 months
for both intervention groups and comparison group.
Table 1 shows the measurement tools of data collection,
Table 1 Measurement domains, survey tools used at each data collection time point
Variable Measurement tools/questions Base-line 6mth 12mth
Demographic measures Sex, age, ethnicity, religion, education, occupation, health insurance, marital status,
anual income, annual household expenditure
√
Health status Time of diagnosis, family history, complications and co-morbidities, smoking, alcohol intake,
frequency of physical exercise, length of diagnosis with diabetes, health education access;
√
therapy, list of a prescribed medications, events of hypoglycemia √ √ √
Psychosocial status Diabetes knowledge √ √ √
Activities of self-management, (SDSCA) √ √ √
Self-efficacy (Diabetes Self-Efficacy Scale) √ √ √
Adherence to medication (Morisky Scale) √ √ √
Quality of life( EQ5-D, DDS) √ √ √
Life satisfaction(SWLS) √ √ √
Trait affect(PANAS) √ √ √
Depression, anxiety and stress( PHQ-9, DASS) √ √ √
Biomedical measures Weight, , height √ √ √
Waist circumference, hip circumference √ √ √
Blood pressure, √ √ √
HbA1c(glycosylated haemoglobin) √ √ √
AGEs( advanced glycation end products ) √ √ √
Blood glucose (fasting plasma glucose and 2 hour post load glucose) √ √ √
Blood Lipids(total cholesterol, low density lipoprotein, high density lipoprotein, triglycerides) √ √ √
Cost Cost of medicine, travel time and fee, escort fee, hospital stays and fee, cost of services, etc. √ √ √
Xie et al. BMC Public Health 2014, 14:747 Page 5 of 7
http://www.biomedcentral.com/1471-2458/14/747the method of data collection and the time points of data
collection.
Data collection consists of two main parts, questionnaire
and biophysical data. The questionnaire data includes four
main parts and will be collected by trained investigators.
The first part covers social demographics (e.g., sex, age,
ethnicity, religion, education level, occupation, health
insurance, marital status, annual income, etc.); the second
portion concerns measures of health status (eg, time of
diagnosis, smoking, alcohol intake, frequency of physical
exercise, therapy, length of diagnosis with diabetes, family
history, complications and co-morbidities, educational
history and type, glucose monitor). The third section
is psychosocial status including knowledge of diabetes;
activities of self-management [15], self-efficacy [16], adher-
ence to medication [17,18], quality of life [19-21], diabetes
distress screening [22,23], traits [24], life satisfaction [25],
depression, anxiety and stress [26-28]. The final section
asks about economic status, which covers training, equip-
ment availability, human resources, drugs, travel fees, escort
fees, communication expenses, consumables, etc.
The biophysical data are collected by specifically trained
staff according to standard operation procedure. Height is
measured using a portable height rod to the nearest
0.1 cm with the participants standing without headgear or
shoes. Weight is measured to the nearest 0.1 kg using a
calibrated, portable, digital weighing scale. Body mass index (BMI) is calculated as weight in kilograms divided
by height in meters squared. Waist circumference is
measured midway between the lowest rib and the top
of the hip bone using the tape measure. Hip circumfer-
ence is taken at the maximum circumference over the
buttocks [29]. Duplicate waist and hip circumference
measurement is taken for approximately 10% of the
participants for quality assurance. Blood pressure meter
and weight scales are calibrated at least weekly. Labora-
tories providing blood analysis are accredited, and all
methods for determining HbA1c% are NGSP approved.
Outcome measures
Outcomes variables are measured at baseline, 6 months,
and 12 months, to both participants and peer leaders.
The primary expected outcome is the change in HbA1c
at baseline compared to the sixth month and baseline to
the twelfth month. HbA1c, a measurement of glycosylated
haemoglobin, is regarded as the gold standard measure of
glycemic control reflecting overall blood glucose values
over the previous 8–12 weeks [30,31]. There is a strong
relationship between HbA1c and the risk of developing
long-term diabetic complications and it is accepted as a
reasonable surrogate for long-term outcomes in indi-
viduals with diabetes. Secondary outcomes are advanced
glycation end products (AGEs) [32,33], blood pressure,
BMI, blood lipids, blood glucose (fasting plasma glucose
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severe hypoglycaemia, diabetes self-care activities, medica-
tion adherence, knowledge, quality of life, diabetes self-
efficacy, traits, life satisfaction, depression, anxiety, and
stress. In addition, cost is also assessed.
Data analysis
Social demographic data and health status of the study
subjects are presented as frequencies (percentage) for
categorical variables, and means ± standard deviations for
continuous variables. Comparison of patients character-
istics between groups will be checked by means of T-
tests or χ2 tests, or non-parametric equivalents. Repeated
measures analysis of variance and multilevel analysis for
longitudinal data will be used to examine longitudinal
differences between groups on primary and secondary
outcome measures. Evaluation of intervention effective-
ness will be by intention to treat using the above statistical
tests. Evidence of clustering by clinic site and primary care
provider will be examined and adjusted for analyses as
needed. If significant differences in baseline characteristics
are found, analyses will be repeated adjusting for these
differences using ANOVA and logistic regression for
multivariate analyses. Analysis of covariance (i.e. linear
regression models for 12-month measurements with
baseline scores and intervention arm as covariates) will
estimate the changes from baseline to 12 months that can
be attributed to the peer support intervention. Sensitivity
analyses will be performed to estimate the effects of miss-
ing data using different assumptions (e.g. imputed values).
The EuroQoL 5 dimensional health state measure (EQ5D)
score at base-line and follow-up can be converted into
utility weights using the EQ5D algorithm [34], which then
allow for the calculation of quality adjusted life years
(QALYs). Economic analyses will be employed to estimate
direct and indirect cost analysis, the cost per QALY gained
and incremental cost-effectiveness ratios. Sensitivity ana-
lysis will be undertaken to test the stability of the analysis
in terms of the cost inputs and health outcomes. All
analyses will be carried out with SPSS 10.0 software.
Qualitative evaluation
A descriptive parallel qualitative analysis is being carried
out to record the attitude of patients, professionals, edu-
cators, rural clinicians and peer leaders to peer support
and their experience of delivery in intervention practices.
The peer leaders will voluntarily participate in a focus
group, semi-structured interviews, or both, to assess
how they experience the training and leading process.
The focus group is designed to reveal the peer leaders’
general attitude and facilitate the development of the
interview guide. Peer leaders are encouraged to discuss
their feelings and efficacy, the training experience, motiva-
tions, as well as any positive and negative impacts on theirown diabetes management. Semi-structured qualitative
interviews and focus group with diabetic patients will also
be carried out and analysed through the investigation and
daily observations. The focus group and interviews are
audio recorded and transcribed.
Discussion
The World Health Organization’s action plan for chronic
disease management helps encouraged governments to
take action to aid people to better managing their own
chronic conditions by providing education, incentives,
self-management tools and care [35]. Implementation of
a diabetes management plan should include clinical care,
diabetes self-management education and ongoing support
[36]. Self-management training and support is an effective
component of care for people with diabetes. Due to a
shortage of time and resources, this critical support is not
consistently delivered in most health care settings. The
study uses trained patients to provide peer support in
urban community. We anticipate that patients in the
intervention arm with a peer leader will show significant
improvement in the biophysical and psychosocial out-
comes, and so will the peer leaders. In addition, we
hypothesize that the recruitment and training of volunteers
with type 2 diabetes as peer leaders to support participants
with the same conditions will be a cost-effective strategy.
We expect that the qualitative and health economic
research will reveal an in-depth perspective on the
impact of this approach both at the level of the patient
as an individual and at the societal level. Successful
implementation of this trial will provide evidence of the
key functions of peer support, identified by the global
Peers for Progress program. Moreover, the results of this
study will influence future policies on diabetes manage-
ment, as well as other chronic diseases in China.
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